| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |